Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Yong

Showing results (151-160 of 198) with videos related to

Pageof 20
Sort By:
Leukemia|August 4, 2007
Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemiaB N Savani, S Mielke, S Adams, et al.
Blood|December 24, 2013
Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cellsEva Nievergall, Hayley S Ramshaw, Agnes S M Yong, et al.
British Journal of Haematology|May 1, 2020
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cellsYazad D Irani, Amy Hughes, Jade Clarson, et al.
Gene Therapy|March 11, 2011
Intratumor RNA interference of cell cycle genes slows down tumor progressionS Dharmapuri, D Peruzzi, E Marra, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2020
Cardiac procedural deferral during the coronavirus (COVID-19) pandemicCelina M Yong, Lawrence Ang, Frederick G P Welt, et al.
Plos One|September 30, 2014
Foxp3 expression in macrophages associated with RENCA tumors in miceChristel Devaud, Carmen S M Yong, Liza B John, et al.
Blood|October 17, 2008
Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomibAgnes S M Yong, Keyvan Keyvanfar, Nancy Hensel, et al.
Circulation|August 17, 2016
Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart AssociationDeborah Rohm Young, Marie-France Hivert, Sofiya Alhassan, et al.
Immunotherapy|June 4, 2013
Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptorMelissa A Henderson, Carmen S M Yong, Connie P M Duong, et al.
Journal of the American College of Cardiology|November 26, 2021
Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United StatesMakoto Mori, Aakriti Gupta, Yun Wang, et al.
Pageof 20

Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
Leukemia|August 4, 2007
Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemiaB N Savani, S Mielke, S Adams, et al.
Blood|December 24, 2013
Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cellsEva Nievergall, Hayley S Ramshaw, Agnes S M Yong, et al.
British Journal of Haematology|May 1, 2020
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cellsYazad D Irani, Amy Hughes, Jade Clarson, et al.
Gene Therapy|March 11, 2011
Intratumor RNA interference of cell cycle genes slows down tumor progressionS Dharmapuri, D Peruzzi, E Marra, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2020
Cardiac procedural deferral during the coronavirus (COVID-19) pandemicCelina M Yong, Lawrence Ang, Frederick G P Welt, et al.
Plos One|September 30, 2014
Foxp3 expression in macrophages associated with RENCA tumors in miceChristel Devaud, Carmen S M Yong, Liza B John, et al.
Blood|October 17, 2008
Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomibAgnes S M Yong, Keyvan Keyvanfar, Nancy Hensel, et al.
Circulation|August 17, 2016
Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart AssociationDeborah Rohm Young, Marie-France Hivert, Sofiya Alhassan, et al.
Immunotherapy|June 4, 2013
Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptorMelissa A Henderson, Carmen S M Yong, Connie P M Duong, et al.
Journal of the American College of Cardiology|November 26, 2021
Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United StatesMakoto Mori, Aakriti Gupta, Yun Wang, et al.
Pageof 20